The long noncoding RNA NRF regulates programmed necrosis and myocardial injury during ischemia and reperfusion by targeting miR-873
暂无分享,去创建一个
W. Kolch | B. Mack | O. Gires | J. Rauch | N. Volinsky | Y. Dong | N. Li | K. Wang | L-Y Zhou | C-Y Liu | P-F Li | D. Vandamme | T. An | B. McCann | J. Zhang | M. Wang | Y-F Zhao | A. Blanco | F. Liu | J-N Gao
[1] M. Ibberson,et al. Discovery and functional characterization of cardiovascular long noncoding RNAs. , 2015, Journal of molecular and cellular cardiology.
[2] A. Bayoumi,et al. Long Non-Coding RNAs as Master Regulators in Cardiovascular Diseases , 2015, International journal of molecular sciences.
[3] C. Bauters,et al. [Potential of non-coding RNA as biomarkers in heart failure]. , 2015, Medecine sciences : M/S.
[4] Zhijian Yang,et al. Altered long noncoding RNA expression profiles in the myocardium of rats with ischemic heart failure , 2015, Journal of cardiovascular medicine.
[5] Yan Li,et al. Interleukin-17 (IL-17)-induced MicroRNA 873 (miR-873) Contributes to the Pathogenesis of Experimental Autoimmune Encephalomyelitis by Targeting A20 Ubiquitin-editing Enzyme* , 2014, The Journal of Biological Chemistry.
[6] Florian Reisinger,et al. RIP3, a kinase promoting necroptotic cell death, mediates adverse remodelling after myocardial infarction. , 2014, Cardiovascular research.
[7] A. Hergovich,et al. The Hippo pathway in disease and therapy: cancer and beyond , 2014, Clinical and Translational Medicine.
[8] Boris N. Kholodenko,et al. Protein interaction switches coordinate Raf-1 and MST2/Hippo signalling , 2014, Nature Cell Biology.
[9] B. Rollins,et al. Somatic activating ARAF mutations in Langerhans cell histiocytosis. , 2014, Blood.
[10] M. Hermiston,et al. A(nother) RAF mutation in LCH. , 2014, Blood.
[11] W. Kolch,et al. HGF induces epithelial-to-mesenchymal transition by modulating the mammalian hippo/MST2 and ISG15 pathways. , 2014, Journal of proteome research.
[12] M. Meyerson,et al. Oncogenic and sorafenib-sensitive ARAF mutations in lung adenocarcinoma. , 2014, The Journal of clinical investigation.
[13] L. Zender,et al. Splicing factor hnRNP A2 activates the Ras-MAPK-ERK pathway by controlling A-Raf splicing in hepatocellular carcinoma development , 2014, RNA.
[14] Ling V. Sun,et al. Mst1 and Mst2 Are Essential Regulators of Trophoblast Differentiation and Placenta Morphogenesis , 2014, PloS one.
[15] S. Rahman,et al. HTLV-1 Tax mediated downregulation of miRNAs associated with chromatin remodeling factors in T cells with stably integrated viral promoter , 2014, Retrovirology.
[16] P. Vandenabeele,et al. Depletion of RIPK3 or MLKL blocks TNF-driven necroptosis and switches towards a delayed RIPK1 kinase-dependent apoptosis , 2014, Cell Death and Disease.
[17] D. Barford,et al. KSR2 Mutations Are Associated with Obesity, Insulin Resistance, and Impaired Cellular Fuel Oxidation , 2013, Cell.
[18] P. Yuan,et al. Functional Role of Mst1/Mst2 in Embryonic Stem Cell Differentiation , 2013, PloS one.
[19] Julian Downward,et al. Hmga2 functions as a competing endogenous RNA to promote lung cancer progression , 2013, Nature.
[20] F. Martín-Belmonte,et al. Crossroads of Wnt and Hippo in epithelial tissues. , 2013, Trends in cell biology.
[21] A. Penzo-Méndez,et al. Hippo signaling regulates differentiation and maintenance in the exocrine pancreas. , 2013, Gastroenterology.
[22] Shuji Takahashi,et al. Hippo signaling components, Mst1 and Mst2, act as a switch between self-renewal and differentiation in Xenopus hematopoietic and endothelial progenitors. , 2013, International Journal of Developmental Biology.
[23] David M. Thomas,et al. The Hippo pathway and human cancer , 2013, Nature Reviews Cancer.
[24] K. Guan,et al. The Hippo pathway: regulators and regulations. , 2013, Genes & development.
[25] Robert E. Lewis,et al. Kinase Suppressor of Ras 2 (KSR2) Regulates Tumor Cell Transformation via AMPK , 2012, Molecular and Cellular Biology.
[26] U. Moll,et al. p53 Opens the Mitochondrial Permeability Transition Pore to Trigger Necrosis , 2012, Cell.
[27] Donncha F. O’Brien,et al. Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects , 2012, Nature Medicine.
[28] P. Doevendans,et al. Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia–reperfusion in vivo , 2012, Basic Research in Cardiology.
[29] Xiaodong Wang,et al. Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase , 2012, Cell.
[30] Chaoqian Xu,et al. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2 , 2011, Nature Medicine.
[31] D. Cacchiarelli,et al. A Long Noncoding RNA Controls Muscle Differentiation by Functioning as a Competing Endogenous RNA , 2011, Cell.
[32] A. Meng,et al. Angiomotin-like2 Gene (amotl2) Is Required for Migration and Proliferation of Endothelial Cells during Angiogenesis* , 2011, The Journal of Biological Chemistry.
[33] Bryan R. Cullen,et al. Reduced Expression of Brain-Enriched microRNAs in Glioblastomas Permits Targeted Regulation of a Cell Death Gene , 2011, PloS one.
[34] D. Stolz,et al. Characterization of DISC formation and TNFR1 translocation to mitochondria in TNF-α-treated hepatocytes. , 2011, The American journal of pathology.
[35] T. Bale,et al. Early Prenatal Stress Epigenetically Programs Dysmasculinization in Second-Generation Offspring via the Paternal Lineage , 2011, The Journal of Neuroscience.
[36] C. Kanduri. Kcnq1ot1: a chromatin regulatory RNA. , 2011, Seminars in cell & developmental biology.
[37] J. Mattick,et al. The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. , 2011, Cancer research.
[38] L. V. Van Laake,et al. miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes , 2011, The Journal of experimental medicine.
[39] W. Kolch,et al. Raf family kinases: old dogs have learned new tricks. , 2011, Genes & cancer.
[40] Junjie Chen,et al. Angiomotin-like Proteins Associate with and Negatively Regulate YAP1* , 2010, The Journal of Biological Chemistry.
[41] L. Maquat,et al. lncRNAs transactivate Staufen1-mediated mRNA decay by duplexing with 3'UTRs via Alu elements , 2010, Nature.
[42] M. Medvedovic,et al. MicroRNA-494 Targeting Both Proapoptotic and Antiapoptotic Proteins Protects Against Ischemia/Reperfusion-Induced Cardiac Injury , 2010, Circulation.
[43] J. Steitz,et al. Down-Regulation of a Host MicroRNA by a Herpesvirus saimiri Noncoding RNA , 2010, Science.
[44] Jiayi Wang,et al. CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer , 2010, Nucleic acids research.
[45] Danish Sayed,et al. MicroRNA-21 Is a Downstream Effector of AKT That Mediates Its Antiapoptotic Effects via Suppression of Fas Ligand* , 2010, The Journal of Biological Chemistry.
[46] F. Chan,et al. Physiological consequences of programmed necrosis, an alternative form of cell demise , 2010, Molecules and cells.
[47] Peifeng Li. MicroRNAs in Cardiac Apoptosis , 2010, Journal of cardiovascular translational research.
[48] Howard Y. Chang,et al. Long noncoding RNA HOTAIR reprograms chromatin state to promote cancer metastasis , 2010, Nature.
[49] W. Kolch,et al. Tumor and Stem Cell Biology Heterogeneous Nuclear Ribonucleoprotein H Blocks Mst2-mediated Apoptosis in Cancer Cells by Regulating A-raf Transcription , 2022 .
[50] Robert E. Lewis,et al. KSR2 is an essential regulator of AMP kinase, energy expenditure, and insulin sensitivity. , 2009, Cell metabolism.
[51] V. Rao,et al. Proteomic characterization of the dynamic KSR-2 interactome, a signaling scaffold complex in MAPK pathway. , 2009, Biochimica et biophysica acta.
[52] Jianqin Jiao,et al. miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy , 2009, Proceedings of the National Academy of Sciences.
[53] Na Zhang,et al. RIP3, an Energy Metabolism Regulator That Switches TNF-Induced Cell Death from Apoptosis to Necrosis , 2009, Science.
[54] T. Veenstra,et al. KSR2 is a calcineurin substrate that promotes ERK cascade activation in response to calcium signals. , 2009, Molecular cell.
[55] Tao Wang,et al. Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-α , 2009, Cell.
[56] F. Chan,et al. Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced Inflammation , 2009, Cell.
[57] J. Olson,et al. DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas , 2009, Journal of cellular and molecular medicine.
[58] John N. Hutchinson,et al. An architectural role for a nuclear noncoding RNA: NEAT1 RNA is essential for the structure of paraspeckles. , 2009, Molecular cell.
[59] Victoria Sanz-Moreno,et al. Ras Subcellular Localization Defines Extracellular Signal-Regulated Kinase 1 and 2 Substrate Specificity through Distinct Utilization of Scaffold Proteins , 2008, Molecular and Cellular Biology.
[60] Jian Yu,et al. PUMA, a potent killer with or without p53 , 2008, Oncogene.
[61] W. Tan,et al. Foxo3a Inhibits Cardiomyocyte Hypertrophy through Transactivating Catalase* , 2008, Journal of Biological Chemistry.
[62] R. Zahedi,et al. Positive Regulation of A-RAF by Phosphorylation of Isoform-specific Hinge Segment and Identification of Novel Phosphorylation Sites* , 2008, Journal of Biological Chemistry.
[63] P. Zamore,et al. Design and delivery of antisense oligonucleotides to block microRNA function in cultured Drosophila and human cells , 2008, Nature Protocols.
[64] A. Pinto,et al. Essential role of ERK dimers in the activation of cytoplasmic but not nuclear substrates by ERK-scaffold complexes. , 2008, Molecular cell.
[65] Ru Wei,et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth , 2008, Nature.
[66] P. Vandenabeele,et al. Caspase-14 reveals its secrets , 2008, The Journal of cell biology.
[67] J. Troppmair,et al. Regulation of pyruvate kinase type M2 by A-Raf: a possible glycolytic stop or go mechanism. , 2007, Anticancer research.
[68] Walter Kolch,et al. RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein. , 2007, Molecular cell.
[69] U. Rapp,et al. Unique N-region Determines Low Basal Activity and Limited Inducibility of A-RAF Kinase , 2007, Journal of Biological Chemistry.
[70] John H. White,et al. Expression of human kinase suppressor of Ras 2 (hKSR-2) gene in HL60 leukemia cells is directly upregulated by 1,25-dihydroxyvitamin D(3) and is required for optimal cell differentiation. , 2007, Experimental cell research.
[71] T. Takenawa,et al. DA-Raf1, a competent intrinsic dominant-negative antagonist of the Ras–ERK pathway, is required for myogenic differentiation , 2007, The Journal of cell biology.
[72] K. Chien,et al. Molecular medicine: MicroRNAs and the tell-tale heart , 2007, Nature.
[73] M. Basson. MicroRNAs loom large in the heart , 2007, Nature Medicine.
[74] J. Marín-García,et al. Oxidative stress enhances phosphorylation of p53 in neonatal rat cardiomyocytes , 2007, Molecular and Cellular Biochemistry.
[75] Michael T. McManus,et al. Dysregulation of Cardiogenesis, Cardiac Conduction, and Cell Cycle in Mice Lacking miRNA-1-2 , 2007, Cell.
[76] Thomas Thum,et al. MicroRNAs in the Human Heart: A Clue to Fetal Gene Reprogramming in Heart Failure , 2007, Circulation.
[77] Takashi Nakakuki,et al. Quantitative transcriptional control of ErbB receptor signaling undergoes graded to biphasic response for cell differentiation. , 2006, The Journal of Biological Chemistry.
[78] Sung Soo Kim,et al. Differential anti-proliferative actions of peroxisome proliferator-activated receptor-gamma agonists in MCF-7 breast cancer cells. , 2006, Biochemical pharmacology.
[79] M. Rijnkels,et al. A noncoding RNA is a potential marker of cell fate during mammary gland development. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[80] Robert E. Lewis,et al. The Molecular Scaffold Kinase Suppressor of Ras 1 Is a Modifier of RasV12-Induced and Replicative Senescence , 2006, Molecular and Cellular Biology.
[81] Z. Weng,et al. A Global Map of p53 Transcription-Factor Binding Sites in the Human Genome , 2006, Cell.
[82] R. Seger,et al. The extracellular signal-regulated kinase: Multiple substrates regulate diverse cellular functions , 2006, Growth factors.
[83] A. Furukawa,et al. H2O2 Accelerates Cellular Senescence by Accumulation of Acetylated p53 via Decrease in the Function of SIRT1 by NAD+ Depletion , 2006, Cellular Physiology and Biochemistry.
[84] N. Rajewsky,et al. Silencing of microRNAs in vivo with ‘antagomirs’ , 2005, Nature.
[85] K. Livak,et al. Real-time quantification of microRNAs by stem–loop RT–PCR , 2005, Nucleic acids research.
[86] W. Kolch. Coordinating ERK/MAPK signalling through scaffolds and inhibitors , 2005, Nature Reviews Molecular Cell Biology.
[87] Y. Choi,et al. Retroviral expression screening of oncogenes in pancreatic ductal carcinoma. , 2005, European journal of cancer.
[88] Jeffrey Robbins,et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death , 2005, Nature.
[89] Tetsuya Watanabe,et al. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death , 2005, Nature.
[90] J. Alan,et al. Protein Kinase C and Epidermal Growth Factor Stimulation of Raf1 Potentiates Adenylyl Cyclase Type 6 Activation in Intact Cells , 2005, Molecular Pharmacology.
[91] Walter Kolch,et al. Role of the Kinase MST2 in Suppression of Apoptosis by the Proto-Oncogene Product Raf-1 , 2004, Science.
[92] Anna R Martirosyan,et al. Differentiation-inducing quinolines as experimental breast cancer agents in the MCF-7 human breast cancer cell model. , 2004, Biochemical pharmacology.
[93] B. Mack,et al. Allogenic antibody-mediated identification of head and neck cancer antigens. , 2004, Biochemical and biophysical research communications.
[94] Robert E. Lewis,et al. The Molecular Scaffold KSR1 Regulates the Proliferative and Oncogenic Potential of Cells , 2004, Molecular and Cellular Biology.
[95] M. Farrar,et al. Membrane Localization, Oligomerization, and Phosphorylation Are Required for Optimal Raf Activation* , 2003, Journal of Biological Chemistry.
[96] V. Kim,et al. The nuclear RNase III Drosha initiates microRNA processing , 2003, Nature.
[97] T. Veenstra,et al. Protein Phosphatase 2A Positively Regulates Ras Signaling by Dephosphorylating KSR1 and Raf-1 on Critical 14-3-3 Binding Sites , 2003, Current Biology.
[98] U. Rapp,et al. Ras signaling: PP2A puts Ksr and Raf in the right place , 2003, Current Biology.
[99] P. Bernardi,et al. The selection between apoptosis and necrosis is differentially regulated in hydrogen peroxide-treated and glutathione-depleted human promonocytic cells , 2003, Cell Death and Differentiation.
[100] R. Kolesnick,et al. Deficiency of kinase suppressor of Ras1 prevents oncogenic ras signaling in mice. , 2003, Cancer research.
[101] Yan-Hsiung Wang,et al. Identification and Characterization of a Novel p300-mediated p53 Acetylation Site, Lysine 305* , 2003, Journal of Biological Chemistry.
[102] M. Kelliher,et al. The Death Domain Kinase RIP Protects Thymocytes from Tumor Necrosis Factor Receptor Type 2–induced Cell Death , 2002, The Journal of experimental medicine.
[103] Kenneth M. Murphy,et al. Kinase Suppressor of Ras (KSR) Is a Scaffold Which Facilitates Mitogen-Activated Protein Kinase Activation In Vivo , 2002, Molecular and Cellular Biology.
[104] T. Schedl,et al. C. elegans ksr-1 and ksr-2 Have Both Unique and Redundant Functions and Are Required for MPK-1 ERK Phosphorylation , 2002, Current Biology.
[105] W. Dai,et al. Reactive Oxygen Species-induced Phosphorylation of p53 on Serine 20 Is Mediated in Part by Polo-like Kinase-3* , 2001, The Journal of Biological Chemistry.
[106] J. Hancock,et al. Protein phosphatases 1 and 2A promote Raf-1 activation by regulating 14-3-3 interactions , 2001, Oncogene.
[107] T. Ohyama,et al. MST, a Physiological Caspase Substrate, Highly Sensitizes Apoptosis Both Upstream and Downstream of Caspase Activation* , 2001, The Journal of Biological Chemistry.
[108] Brian Seed,et al. Fas triggers an alternative, caspase-8–independent cell death pathway using the kinase RIP as effector molecule , 2000, Nature Immunology.
[109] W. Kolch,et al. Raf-1-associated Protein Phosphatase 2A as a Positive Regulator of Kinase Activation* , 2000, The Journal of Biological Chemistry.
[110] A. Yuryev,et al. Isoform-Specific Localization of A-RAF in Mitochondria , 2000, Molecular and Cellular Biology.
[111] C. Herrmann,et al. Mitogenic signaling of Ras is regulated by differential interaction with Raf isozymes , 2000, Oncogene.
[112] R. von Harsdorf,et al. p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c‐independent apoptosis blocked by Bcl‐2 , 1999, The EMBO journal.
[113] C. di Loreto,et al. Myocyte death in the failing human heart is gender dependent. , 1999, Circulation research.
[114] M. Raff,et al. Caspase activation in the terminal differentiation of human epidermal keratinocytes , 1999, Current Biology.
[115] V. Rotter,et al. Hydrogen peroxide induces nuclear translocation of p53 and apoptosis in cells of oligodendroglia origin. , 1999, Brain research. Molecular brain research.
[116] H. Endou,et al. Hydrogen Peroxide Induces Necrosis, Apoptosis, Oncosis and Apoptotic Oncosis of Mouse Terminal Proximal Straight Tubule Cells , 1999, Nephron.
[117] J. McCubrey,et al. Differential abilities of activated Raf oncoproteins to abrogate cytokine dependency, prevent apoptosis and induce autocrine growth factor synthesis in human hematopoietic cells , 1998, Leukemia.
[118] S. Ménard,et al. Increased expression of c-erbB-2 in hormone-dependent breast cancer cells inhibits cell growth and induces differentiation , 1998, Oncogene.
[119] W. Fiers,et al. Inhibition of Caspases Increases the Sensitivity of L929 Cells to Necrosis Mediated by Tumor Necrosis Factor , 1998, The Journal of experimental medicine.
[120] E. Krebs,et al. Caspase‐mediated activation and induction of apoptosis by the mammalian Ste20‐like kinase Mst1 , 1998, The EMBO journal.
[121] R. Peshock,et al. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. , 1998, Circulation.
[122] C. Marshall,et al. Differential Regulation of Raf-1, A-Raf, and B-Raf by Oncogenic Ras and Tyrosine Kinases* , 1997, The Journal of Biological Chemistry.
[123] G. Rubin,et al. KSR modulates signal propagation within the MAPK cascade. , 1996, Genes & development.
[124] S. Schreiber,et al. Controlling protein association and subcellular localization with a synthetic ligand that induces heterodimerization of proteins. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[125] E. Lalani,et al. bcl-2: role in epithelial differentiation and oncogenesis. , 1996, Human pathology.
[126] C. Rommel,et al. Activated Ras displaces 14-3-3 protein from the amino terminus of c-Raf-1. , 1996, Oncogene.
[127] H. Horvitz,et al. The ksr-1 gene encodes a novel protein kinase involved in Ras-mediated signaling in C. elegans , 1995, Cell.
[128] Min Han,et al. The C. elegans ksr-1 gene encodes a novel raf-related kinase involved in Ras-mediated signal transduction , 1995, Cell.
[129] Henry C. Chang,et al. KSR, a novel protein kinase required for RAS signal transduction , 1995, Cell.
[130] C. Pritchard,et al. Conditionally oncogenic forms of the A-Raf and B-Raf protein kinases display different biological and biochemical properties in NIH 3T3 cells , 1995, Molecular and cellular biology.
[131] J. Hancock,et al. Activation of Raf as a result of recruitment to the plasma membrane. , 1994, Science.
[132] Sally J. Leevers,et al. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane , 1994, Nature.
[133] S. Elledge,et al. Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1 , 1993, Nature.
[134] M. Weber,et al. Complexes of Ras.GTP with Raf-1 and mitogen-activated protein kinase kinase. , 1993, Science.
[135] Paul W. Sternberg,et al. C. elegans lin-45 raf gene participates in let-60 ras-stimulated vulval differentiation , 1993, Nature.
[136] S. Barni,et al. Enhanced secretion of tumour necrosis factor in patients with myocardial infarction. , 1992, European Journal of Medicine.
[137] R. Lupu,et al. A ligand for the erbB-2 oncogene product (gp30) induces differentiation of human breast cancer cells. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[138] J. Cohen,et al. Programmed cell death in terminally differentiating keratinocytes: role of endogenous endonuclease. , 1991, The Journal of investigative dermatology.
[139] N. Gas,et al. Effects of differentiation‐inducing agents on maturation of human MCF‐7 breast cancer cells , 1990, Journal of cellular physiology.
[140] G. Gould,et al. Expression of c-raf-1 and A-raf-1 during differentiation of 3T3-L1 preadipocyte fibroblasts into adipocytes. , 1989, Biochemical and biophysical research communications.
[141] S. Hsu,et al. The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics. , 1981, American journal of clinical pathology.
[142] Yanrui Li,et al. miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1 , 2011, Nature Medicine.
[143] K. Guan,et al. Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. , 2011, Genes & development.
[144] S. Dimmeler,et al. Control of cardiovascular differentiation by microRNAs , 2010, Basic Research in Cardiology.
[145] U. Rapp,et al. RAF expression in human astrocytic tumors. , 2009, International journal of molecular medicine.
[146] P. Vandenabeele,et al. Caspases in cell survival, proliferation and differentiation , 2007, Cell Death and Differentiation.
[147] 寺井 健太. Ras binding opens c-Raf to expose the docking site for mitogen-activated protein kinase kinase , 2006 .
[148] S. Schreiber,et al. Dimerization as a regulatory mechanism in signal transduction. , 1998, Annual review of immunology.
[149] A. Lichtenstein,et al. Apoptotic vs. nonapoptotic cytotoxicity induced by hydrogen peroxide. , 1997, Free radical biology & medicine.
[150] D. Yellon,et al. Inability of dimethylthiourea to limit tissue necrosis during acute myocardial infarction in rabbits. , 1992, Free radical biology & medicine.
[151] J. Downey,et al. Free radicals and their involvement during long-term myocardial ischemia and reperfusion. , 1990, Annual review of physiology.